Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

tDCS Stimulation Combined With VI as a Possible Therapy for Enhancing Functional Ability in SCI With Neuropathic Pain

NCT03052244 is registered in ClinicalTrials.gov with Loewenstein Hospital as lead sponsor.

NCT NCT03052244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03052244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
tDCS Stimulation Combined With VI as a Possible Therapy for Enhancing Functional Ability in SCI With Neuropathic Pain
Lead sponsor
Loewenstein Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 15, 2017
Completion date
March 15, 2020
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sci - spinal cord injury